Trending stocks

Saputo Inc revenue growth decelerated to 15.4% in FY2015 vs. 26.5% a year earliner

04.06.2015 • About Saputo Inc ($SAP) • By InTwits

Saputo Inc reported FY2015 financial results today. Overall the company's long term financial model is characterised by the following facts:
  • Saputo Inc is a growth stock: FY2015 revenue growth was 15.4%, 5 year revenue CAGR was 12.9% at FY2015 ROIC 16.5%
  • Saputo Inc has low CAPEX intensity: 5 year average CAPEX/Revenue was 2.0%. At the same time it's in pair with industry average of 8.1%.
  • CAPEX is quite volatile: 516 in FY2015, 539 in FY2014, 404 in FY2013, 222 in FY2012, 231 in FY2011
  • The company has highly profitable business model: ROIC is at 16.5%
Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.

Saputo Inc ($SAP) key annual financial indicators

mln. CAD201120122013201420152015/2014
P&L
Revenue6,0036,9307,2989,23310,65815.4%
Gross Profit7888318611,0201,0624.1%
EBITDA7888318189751,09412.3%
Net Income45038148253360814.0%
Balance Sheet
Cash7714443397384.4%
Short Term Debt171167334704223-68.3%
Long Term Debt3783801,3961,3961,5178.7%
Cash flow
Capex112119178224187-16.4%
Ratios
Revenue growth3.3%15.4%5.3%26.5%15.4%
EBITDA growth13.9%5.4%-1.5%19.1%12.3%
Gross Margin13.1%12.0%11.8%11.1%10.0%-1.1%
EBITDA Margin13.1%12.0%11.2%10.6%10.3%-0.3%
Net Income Margin7.5%5.5%6.6%5.8%5.7%-0.1%
CAPEX, % of revenue1.9%1.7%2.4%2.4%1.8%-0.7%
ROIC23.8%24.6%19.2%17.0%16.5%-0.5%
ROE21.9%18.2%21.8%21.0%19.2%-1.8%
Net Debt/EBITDA0.6x0.5x2.1x2.1x1.5x-0.6x

Revenue and profitability


Saputo Inc's Revenue jumped on 15.4% in FY2015. EBITDA Margin showed almost no change in FY2015.

Gross Margin decreased slightly on 1.1 pp from 11.1% to 10.0% in FY2015.

Net Income marign showed almost no change in FY2015.

Capital expenditures (CAPEX) and working capital investments


In FY2015 the company had CAPEX/Revenue of 1.8%. Saputo Inc showed almost no change in CAPEX/Revenue from FY2012 to FY2015. It's average level of CAPEX/Revenue for the last three years was 2.2%.

Return on investment


The company operates at good ROIC (16.47%) and ROE (19.18%). ROIC decreased slightly on 0.50 pp from 17.0% to 16.5% in FY2015. ROE decreased slightly on 1.8 pp from 21.0% to 19.2% in FY2015.

Leverage (Debt)


Debt level is 1.5x Net Debt / EBITDA and 1.6x Debt / EBITDA. Net Debt / EBITDA dropped on 0.6x from 2.1x to 1.5x in FY2015. Debt dropped on 17.1% in FY2015 while cash surged on 84.4% in FY2015.

Management team


Lino A Saputo Jr is a the company's CEO. Lino A Saputo Jr is a founder and has spent 14 years at the company.

Appendix 1: Peers in Consumer, Non-cyclical


Below we provide Saputo Inc benchmarking against other companies in Consumer, Non-cyclical industry for the last 5 years. We show data for the top-5 companies by key financial metric together with the median value for all the companies in the industry.

Top companies by Revenue growth, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
GDI Integrated Facility Services Inc ($GDI)43.8%-38.8%-72.9%218,969.1%
Cardiome Pharma Corp ($COM)-97.7%-47.6%471.7%566.0%
Family Memorials Inc ($FAM)-13.6%54.7%22.9%245.3%
Nobilis Health Corp ($NHC)16.6%45.3%49.0%169.9%
Concordia Healthcare Corp ($CXR)159.5%
 
Median (85 companies)11.2%7.7%6.9%12.2%5.3%
Saputo Inc ($SAP)15.4%5.3%26.5%15.4%


Top companies by Gross margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Nobilis Health Corp ($NHC)99.8%
Cipher Pharmaceuticals Inc ($CPH)99.5%98.3%
Heritage Global Inc ($HGP)99.5%95.7%
Ritchie Bros Auctioneers Inc ($RBA)87.9%88.7%88.4%88.0%
Concordia Healthcare Corp ($CXR)79.4%86.0%
 
Median (73 companies)35.4%37.4%36.1%35.6%28.6%
Saputo Inc ($SAP)13.1%12.0%11.8%11.1%10.0%


Top companies by EBITDA margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Cipher Pharmaceuticals Inc ($CPH)-50.0%40.6%71.4%63.7%
Merus Labs International Inc ($MSL)32.9%64.7%46.2%
Valeant Pharmaceuticals International Inc ($VRX)37.0%30.6%27.8%45.6%
EnerCare Inc ($ECI)59.0%52.8%51.0%45.5%
Information Services Corp ($ISV)34.1%39.6%39.6%37.6%
 
Median (84 companies)7.9%7.9%8.3%10.7%-92.5%
Saputo Inc ($SAP)13.1%12.0%11.2%10.6%10.3%


Top companies by CAPEX/Revenue, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Neptune Technologies & Bioressources Inc ($NTB)6.0%4.7%73.6%84.6%119.0%
CanaDream Corp ($CDN)68.6%43.3%38.1%70.4%
Ceapro Inc ($CZO)2.2%3.9%35.3%52.0%
Feronia Inc/Canada ($FRN)129.0%191.4%117.4%42.4%
Microbix Biosystems Inc ($MBX)1.0%1.2%3.0%40.3%
 
Median (85 companies)2.4%2.6%2.4%2.6%5.4%
Saputo Inc ($SAP)1.9%1.7%2.4%2.4%1.8%


Top companies by ROIC, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Biosyent Inc ($RX)45.5%71.7%62.4%62.9%
Information Services Corp ($ISV)56.0%71.8%72.8%58.9%
Covalon Technologies Ltd ($COV)-49.6%-75.8%-30.1%50.6%
Cipher Pharmaceuticals Inc ($CPH)-22.9%21.8%81.4%44.6%
Ceapro Inc ($CZO)69.9%-33.5%15.5%43.5%
 
Median (85 companies)7.4%6.7%6.7%6.9%6.8%
Saputo Inc ($SAP)23.8%24.6%19.2%17.0%16.5%


Top companies by Net Debt / EBITDA

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Noble Iron Inc ($NIR)25.5x12.9x227.3x
Family Memorials Inc ($FAM)15.2x
Amica Mature Lifestyles Inc ($ACC)11.7x9.4x14.7x13.8x
Cott Corp ($BCB)2.6x2.0x2.2x13.4x
CRH Medical Corp ($CRH)-2.3x-3.1x-3.5x12.0x
 
Median (69 companies)1.9x2.8x2.2x2.7x1.7x
Saputo Inc ($SAP)0.6x0.5x2.1x2.1x1.5x